![](/Jwk_zgyxzz/develop/static/common/images/pdf.png)
门冬胰岛素30和精蛋白生物合成人胰岛素30R治疗2型糖尿病的成本-效果分析
Cost-Effectiveness Analysis of Insulin Aspart30 Versus Premixed Human Insulin 30/70 in Patients with Type 2 Diabetes in China
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|